Titration activities from baseline up to 6 and 12 months follow-up in nurse-coordinated care (NCC) versus usual care patients. X-as: patients (percentage),

Slides:

Advertisements

Similar presentations

Weng TC, et al. J Clin Pharm Ther 2010;35:

Advertisements

THE COMMONWEALTH FUND Source: McCarthy and Leatherman, Performance Snapshots, Percentage of Community-Dwelling Adults Ages.

Cholesterol-Lowering Ability of a Phytostanol Softgel Supplement in Adults with Mild to Moderate Hypercholesterolemia Woodgate D et al. Lipids. 2006;41:

Plant stanol esters in low-fat yogurt reduces total and low-density lipoprotein cholesterol and low-density lipoprotein oxidation in normocholesterolemic.

Percentage of Community-Dwelling Adults Ages 18 and Older Who Had Their Blood Cholesterol Checked Within the Past Five Years, 1998 and 2003 Data: National.

LIPID PROFILE OF EARLY RHEUMATOID ARTHRITIS PATIENTS

Copyright © 2002 American Medical Association. All rights reserved.

Behavior and Biology: The Basic Sciences for AHA Action

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

Association of low eosinophil and lymphocyte counts with different initial presentations of cardiovascular disease over the first 6 months ‘Low eosinophils’

Charles R. Harper, MD, Terry A. Jacobson, MD Mayo Clinic Proceedings

Longitudinal integrity assessed using bench testing (A, upper panel).

Charles R. Harper, MD, Terry A. Jacobson, MD Mayo Clinic Proceedings

Distribution of lifespan for men initiating preventative therapy (with a risk reduction of 30%) at the age of 50, with national average blood pressure.

Fellström BC, et al. N Engl J Med 2009;360:1455-7

OR (95% CI) for CHD associated with inflammatory markers before and after adjustment for established risk factors. OR (95% CI) for CHD associated with.

MACE rate among CAD severity groups (total 0

P2Y12 blockade versus placebo; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.

I. Introduction American Journal of Kidney Diseases

The effect of GOODCOLL versus POORCOLL on LVEF, LVEDV and scar at 4 months. The effect of GOODCOLL versus POORCOLL on LVEF, LVEDV and scar at 4 months.

Level of risk factor control in the overall sample and by gender

Hajer GR et al. Atherosclerosis 2009;202:216-24

Q.A. Truong et al. Circ Cardiovasc Qual Outcomes 2011;4:

Forest plot of risk ratio with its 95% CI for the incidence of contrast-induced nephropathy among patient taking statin versus control based on renal impairment.

Baseline Characteristics, Values at 24-Month Follow-up, and Changes from Baseline* - Part I John J.P. Kastelein, et al. N Engl J Med 2007;356: online.

Relationship between the premature ventricular contraction (PVC) prevalence and change in left ventricular diastolic dimension (ΔLVDd) during the 4-year.

Body mass, BMI, plasma lipids, lipoproteins, and glucose homeostasis at baseline, and following placebo and rosuvastatin periods Dmitri Sviridov et al.

Flow of Patients Through the Trial

HOMA calculations where glucose is mmol/L and insulin is mU/L

Baseline Characteristics of the Subjects*

Disposition of Patients in the Atherogenic Dyslipidemia Study

Rhanderson Cardoso, MD, Roger S

(A) Low-density lipoprotein-cholesterol (LDL-C) values at baseline and after treatment with anagliptin in 20 participants at 12 and 24 weeks. (A) Low-density.

Kaplan-Meier curves showing the time in months to the first inappropriate shock from the start of remote monitoring in primary and secondary prevention.

Bland Altman analyses comparing minimum luminal area (MLA; upper panel) and diameter (MLD; lower panel) obtained using FD-OCT and IVUS. FD-OCT, frequency.

The volume per centre plotted against clinical outcomes which included Hospital Anxiety and Depression Scale (HADS) score, exercise 150 min, smoking, body.

Distribution of relative percentage change ((post-AVR−pre-AVR)/pre-AVR) in the patients’ absolute pVO2 values between pre-AVR and post-AVR after 9 months.

(A) Absolute and (B) change from baseline in 6 min walk distance over time for all patients and by Down syndrome status. (A) Absolute and (B) change from.

Flow-mediated and nitrate-mediated dilation in following radial artery catheterisation. Flow-mediated and nitrate-mediated dilation in following radial.

Change in 6 min walk distance from baseline to each follow-up time for subjects randomised to CABG and to medical therapy alone. The median change and.

Cost of healthcare and sick leave before and after heart valve surgery (€). Cost of healthcare and sick leave before and after heart valve surgery (€).

The following slides highlight a report on a presentation at the American College of Cardiology 2004, Scientific Sessions, in New Orleans, Louisiana on.

Different behaviours between group 1 and group 2 patients of the mean and SD of Δ for low frequency (LF), high frequency (HF) and total power (TP) calculated.

Scatter plot of estimated joint density of incremental costs and incremental effects (quality-adjusted life years (EuroQol five-dimension questionnaire,

(A) Absolute and B) change from baseline in 6 min walk distance over time for patients on bosentan monotherapy by Down syndrome status. (A) Absolute and.

The 6MWT results showing improvement from baseline at 1, 6 and 12 months in patients receiving an implant (mean±SE of mean). The 6MWT results showing improvement.

Relationship between selected metabolic parameters and the primary composite end point. Relationship between selected metabolic parameters and the primary.

Comparison of outcomes in patients with versus patients without diabetes; primary outcome event rate (CV death, non-fatal MI and non-fatal CVA) as a percentage.

Standard mean difference of change in creatinine between the intravenous (IV) versus oral (PO) arm. Standard mean difference of change in creatinine between.

Number of patients who would have benefitted from addition of ACE inhibitor (ACEi), beta blockers (BB) or optimal therapy (one or both of ACEi and BB)

Amir A. Mahabadi et al. JIMG 2017;10:

Flow of study participants

A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.

III. Treating dyslipidemias

Organization as an Enabler of High Performance

Prasugrel versus clopidogrel; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.

Individual lipid measures for high-carbohydrate (n=10) and low-carbohydrate (n=10) ultra-endurance athletes. Individual lipid measures for high-carbohydrate.

Calculating the overall accuracy in different samples using the V-plot

LDL-c reductions below 1

Use of evidence-based cardiac medications before, during and after hospitalisation for the index event in (A) overall ACS population and (B) patients with.

One-year costs by evaluation strategy.

Differences in changes in total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides (expressed as mg/dL) between patients with hyperlipidaemia.

Prasugrel and ticagrelor versus clopidogrel; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial.

HR for mortality in ischemic heart disease.

HR for myocardial infarction.

(A) Kaplan-Meier estimates of MACCE in patients with a non-culprit MaxLCBI4mm ≥400 and MaxLCBI4mm

Kaplan-Meier curves showing the probability of symptom-free survival according to the rate of heart rate rise during exercise testing in (A) for the whole.

The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.

Receiver operating characteristic curve showing results for two selected models, applied to the testing cohort. Receiver operating characteristic curve.

Medication intensity (ALLP) changes between baseline and 6 months, by (not) being low-density lipoprotein-cholesterol (LDL-C) target at baseline for nurse-coordinated.

Presentation transcript:

Titration activities from baseline up to 6 and 12 months follow-up in nurse-coordinated care (NCC) versus usual care patients. X-as: patients (percentage), Y-as: titration activities. Titration activities from baseline up to 6 and 12 months follow-up in nurse-coordinated care (NCC) versus usual care patients. X-as: patients (percentage), Y-as: titration activities. Up-titration and down titrations are relative to baseline. Percentages are % of total population (upper panel) and % of population not on target (lower panel). All p values are calculated with the relevant parameter (down-titration, up-titration or any titration) versus no titration (none). Upper panel: percentage of patients with titrations of total population. All patients: Usual care at 6 months n=328, NCC at 6 months n=331, usual care at 12 months n=316, NCC at 12 months n=315. Lower panel: percentage of patients with titrations of patient population not on low-density lipoprotein-cholesterol (LDL-C) target at baseline: Usual care at 6 months n=94, NCC at 6 months n=100; usual care at 12 months n=89, NCC at 12 months n=90. Not on target is defined as LDL-C >2.5 mmol/L. Analysis applied for patients on lipid-lowering medication and patients with complete medication data. Marjolein Snaterse et al. Open Heart 2017;4:e000607 ©2017 by British Cardiovascular Society